AST-1306
|
|
AST-1306 Eigenschaften
- Siedepunkt:
- 655℃
- Dichte
- 1.395
- Flammpunkt:
- 350℃
- storage temp.
- Store at -20°C
- L?slichkeit
- ≥22.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
- Aggregatzustand
- solid
- pka
- 12.16±0.43(Predicted)
- Farbe
- White to off-white
- InChIKey
- MVZGYPSXNDCANY-UHFFFAOYSA-N
- SMILES
- C(NC1C=CC2C(C=1)=C(NC1=CC=C(OCC3=CC=CC(F)=C3)C(Cl)=C1)N=CN=2)(=O)C=C
Sicherheit
AST-1306 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB4 with IC50 of 0.5 nM and 0.8 nM, respectively.AST-1306 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
AST-1306 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 108)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 33024 | 60 |
Alchem Pharmtech,Inc. | 8485655694 |
sales@alchempharmtech.com | United States | 63687 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
factory@coreychem.com | China | 29804 | 58 |
TargetMol Chemicals Inc. | +17819995354 |
marketing@targetmol.com | United States | 32375 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 |
sales@sarms4muscle.com | China | 10473 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6391 | 58 |
LEAP CHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 24727 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 |
sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38832 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8467 | 58 |
- AST-1306
- ALS 1306
- N-[4-[[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino]quinazolin-6-yl]acrylamide
- N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide
- Allitinib (AST1306)
- Allitinib
- CS-590
- N-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)acrylamide
- 2-Propenamide, N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-
- anilino-quinazoline,Inhibitor,anti-cancer,Epidermal growth factor receptor,ALS1306,Allitinib,Irreversible,HER1,inhibit,AST1306,AST 1306,ALS-1306,ErbB-1,EGFR
- Allitinib, 10 mM in DMSO
- AST-1306 ,E0822
- 897383-62-9